Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted nanomedicine modalities for prostate cancer treatment
Lital Cohen, Yoav D. Livney, Yehuda G. Assaraf
Drug Resistance Updates (2021) Vol. 56, pp. 100762-100762
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 134
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 83
Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 66
Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death
Yu Li, Yuhui Du, Yujie Zhou, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 55
Tumor‐Targeted Glutamine Metabolism Blocker Synergizes with TiO2‐Au Janus Nanoparticles for Enhanced Sono‐Metabolic Antitumor Therapy
Jinling Zheng, Fenghuan Zhao, Eugenie Pariente, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 48
PEGylated Manganese–Zinc Ferrite Nanocrystals Combined with Intratumoral Implantation of Micromagnets Enabled Synergetic Prostate Cancer Therapy via Ferroptotic and Immunogenic Cell Death
Hui Wang, Yu Guan, Chun Li, et al.
Small (2023) Vol. 19, Iss. 22
Closed Access | Times Cited: 21
Nanotherapeutics for prostate cancer treatment: A comprehensive review
Ruimin Hu, Lan Jin, Dinglin Zhang, et al.
Biomaterials (2024) Vol. 305, pp. 122469-122469
Closed Access | Times Cited: 7
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 28
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, et al.
Environmental Research (2023) Vol. 235, pp. 116573-116573
Closed Access | Times Cited: 16
Current progress of nanomedicine for prostate cancer diagnosis and treatment
Jiang Zhao, Chi Zhang, Weihao Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113714-113714
Open Access | Times Cited: 26
Biomolecule-functionalized nanoformulations for prostate cancer theranostics
Pranav Tiwari, Partha Laskar, Meena Jaggi, et al.
Journal of Advanced Research (2022) Vol. 51, pp. 197-217
Open Access | Times Cited: 25
Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer
Amit Kumar, Akshay Kumar Lunawat, Ashutosh Kumar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 3
Closed Access | Times Cited: 4
Progress and application of intelligent nanomedicine in urinary system tumors
Yingming Xiao, Lei Zhong, Jinpeng Liu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 12, pp. 100964-100964
Open Access | Times Cited: 3
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 3
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21
Mitochondrial outer membrane protein MTUS1/ATIP1 exerts antitumor effects through ROS-induced mitochondrial pyroptosis in head and neck squamous cell carcinoma
Dongxiao Tang, Luodan Zhao, Shuojin Huang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2576-2591
Open Access | Times Cited: 2
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
Renjith P. Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100865-100865
Closed Access | Times Cited: 13
Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment
Lital Cohen, Yehuda G. Assaraf, Yoav D. Livney
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 88-88
Open Access | Times Cited: 14
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
Qingmei Ye, Xin Zhou, Fangxuan Han, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 5
Nanomedicine for urologic cancers: diagnosis and management
Chunyang Li, Xiaoxi Zeng, Shi Qiu, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 463-475
Closed Access | Times Cited: 9
Enhanced In Vitro Antiviral Activity of Ivermectin-Loaded Nanostructured Lipid Carriers against Porcine Epidemic Diarrhea Virus via Improved Intracellular Delivery
Xiaolin Xu, Shasha Gao, Qindan Zuo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 601-601
Open Access | Times Cited: 1
Cell-to-cell heterogeneous association of prostate cancer with gold nanoparticles elucidated by single-cell inductively coupled plasma mass spectrometry
Silvana Ruella de Oliveira, Katiuska Tuttis, Ana Rita Thomazela Machado, et al.
Microchemical Journal (2022) Vol. 177, pp. 107275-107275
Closed Access | Times Cited: 5
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and Peroxidation
Tongyu Tong, Hanqi Lei, Shiqiang Zhang, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 23
Closed Access | Times Cited: 4
Corrole Nanoparticles for Chemotherapy of Castration-Resistant Prostate Cancer and as Sonodynamic Agents for Pancreatic Cancer Treatment
Matan Soll, Vinay K. Sharma, Sally Khoury, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 766-776
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top